Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's Disease (PD COMM pilot): study protocol for a randomised controlled trial

Catherine M. Sackley, Christina H. Smith, Caroline Rick, Marian C. Brady, Natalie Ives, Ramilla Patel, Helen Roberts, Francis Dowling, Susan Jowett, Keith Wheatley, Smitta Patel, Debbie Kelly, Gina Sands, Carl Clarke

Research output: Contribution to journalArticle

Abstract

Parkinson’s disease is a common movement disorder affecting approximately 127,000 people in the UK, with an estimated two thirds having speech-related problems. Currently there is no preferred approach to speech and language therapy within the NHS and there is little evidence for the effectiveness of standard NHS therapy or Lee Silverman voice treatment. This trial aims to investigate the feasibility and acceptability of randomizing people with Parkinson’s disease-related speech or voice problems to Lee Silverman voice treatment or standard speech and language therapy compared to a no-intervention control.
Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalTrials
Volume15
Issue number213
Early online date7 Jun 2014
DOIs
Publication statusPublished - Jun 2014

Keywords

  • Parkinson's disease
  • speech and language therapy
  • Lee Silverman voice treatment
  • randomised controlled trial

Fingerprint Dive into the research topics of 'Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's Disease (PD COMM pilot): study protocol for a randomised controlled trial'. Together they form a unique fingerprint.

  • Cite this

    Sackley, C. M., Smith, C. H., Rick, C., Brady, M. C., Ives, N., Patel, R., Roberts, H., Dowling, F., Jowett, S., Wheatley, K., Patel, S., Kelly, D., Sands, G., & Clarke, C. (2014). Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's Disease (PD COMM pilot): study protocol for a randomised controlled trial. Trials, 15(213), 1-7. https://doi.org/10.1186/1745-6215-15-213